PUBLIC CONTRACT · 2021
4180438/2021 - Aq. Central S646 - Sugamadex 200 mg (100MG/ml AMP 2ML) sol inj AMP
- Contract value
- €18,574.00
- Signed on
- 16 December 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 8732692PUBLISHED SUBJECT
4180438/2021 - AQ. CENTRAL S646 - SUGAMADEX 200 MG (100MG/ML AMP 2ML) SOL INJ AMP
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Merck Sharp & Dohme, Lda. · Tax ID 500191360
Values and timeline
- Contract price
- €18,574.00
- Procedure base price
- €18,574.00
- Total effective price
- €18,574.00
- Publication date
- 18 January 2022
- Award date
- 16 December 2021
- Signing date
- 16 December 2021
- Performance period
- 4 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2020/50 - Medicação antialérgica, vitaminas e sais minerais, medicamentos usados no tratamento de intoxicações e grupo 20.9 - outros produtos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5740706
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.